Lexology March 13, 2024
Harris Sliwoski LLP

Table of Contents

Many people struggling with treatment-resistant depression, which does not respond to at least two types of treatment, are finally experiencing relief with intravenous ketamine therapy.

Hundreds of ketamine clinics have been popping up across the country in recent years, and researchers claim infusing or injecting the drug has the potential to treat a wide range of conditions that have been difficult to manage in the past.

The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Mental Health, Patient / Consumer, Provider
The silent struggles of men’s mental health and suicide prevention
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
The Future of Behavioral Health Delivery
Fixing the Growing Payer-Provider Divide in Behavioral Health
Workers Feel “Stuck,” Under-Insured, Financially Stressed, and Neglecting Mental Health

Share This Article